Framework Agreement for Supply of Adalimumab and Golimumab

This tender is a framework agreement for the supply of medicinal products Adalimumab and Golimumab, managed by Consorci de Salut i d'Atenció Social de Catalunya for the Catalonia region (Spain). The procedure is open with electronic submission required. The notice lacks estimated value, award criteria, and selection criteria, increasing uncertainty. The deadline for submission is 2026-07-09T13:00:00 (local time). One lot covers all supplies. The framework agreement duration is stated as 1 year, but the XML notice suggests a possible 48-month duration, creating inconsistency.